Russia’s Ministry of Health has announced the development of an mRNA vaccine against cancer, which will be distributed to patients free of charge. The vaccine was developed in collaboration with several research centers and is planned to be launched in general circulation in early 2025. According to the Director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Gintsburg, the vaccine’s pre-clinical trials have shown that it suppresses tumor development and potential metastases. The vaccine will be personalized to each patient and is intended to treat cancer patients, rather than being given to the general public to prevent cancer.
According to Andrey Kaprin, the General Director of the Radiology Medical Research Center of the Russian Ministry of Health, the vaccine is expected to be available in early 2025. Preclinical trials have shown that this vaccine can suppress tumor growth by 75-80%. Specifics such as the types of cancer it targets, its effectiveness, and the exact method of distribution remain unclear. The name of the vaccine has not been disclosed.